nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC5—Fluorouracil—pancreatic cancer	0.268	0.406	CbGbCtD
Adefovir Dipivoxil—SLC22A3—Irinotecan—pancreatic cancer	0.165	0.25	CbGbCtD
Adefovir Dipivoxil—ABCC4—Fluorouracil—pancreatic cancer	0.129	0.195	CbGbCtD
Adefovir Dipivoxil—ABCC4—Sunitinib—pancreatic cancer	0.0977	0.148	CbGbCtD
Adefovir Dipivoxil—NME1—Gefitinib—Erlotinib—pancreatic cancer	0.00386	0.7	CbGdCrCtD
Adefovir Dipivoxil—NME1—Loperamide—Tamoxifen—pancreatic cancer	0.00165	0.3	CbGdCrCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000685	0.00651	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—pancreatic cancer	0.000677	0.00644	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—CTNNB1—pancreatic cancer	0.000664	0.00631	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000661	0.00629	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—pancreatic cancer	0.000653	0.0062	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000647	0.00615	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000599	0.00569	CbGpPWpGaD
Adefovir Dipivoxil—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000597	0.00259	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Gemcitabine—pancreatic cancer	0.000596	0.00258	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Fluorouracil—pancreatic cancer	0.000593	0.00257	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Erlotinib—pancreatic cancer	0.000593	0.00257	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—SRC—pancreatic cancer	0.00059	0.00561	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000589	0.0056	CbGpPWpGaD
Adefovir Dipivoxil—Cough increased—Doxorubicin—pancreatic cancer	0.000586	0.00254	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000583	0.00554	CbGpPWpGaD
Adefovir Dipivoxil—Hepatocellular injury—Epirubicin—pancreatic cancer	0.000579	0.00251	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Docetaxel—pancreatic cancer	0.000576	0.0025	CcSEcCtD
Adefovir Dipivoxil—Cough—Sunitinib—pancreatic cancer	0.000576	0.00249	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000573	0.00248	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Epirubicin—pancreatic cancer	0.000569	0.00247	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MMP9—pancreatic cancer	0.000567	0.00539	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000567	0.00246	CcSEcCtD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—PIK3CA—pancreatic cancer	0.000565	0.00537	CbGpPWpGaD
Adefovir Dipivoxil—Creatinine increased—Doxorubicin—pancreatic cancer	0.000563	0.00244	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Sunitinib—pancreatic cancer	0.000562	0.00243	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Sunitinib—pancreatic cancer	0.000562	0.00243	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Doxorubicin—pancreatic cancer	0.00056	0.00243	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000558	0.00242	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Tamoxifen—pancreatic cancer	0.000553	0.0024	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.00055	0.00238	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Erlotinib—pancreatic cancer	0.000547	0.00237	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Tamoxifen—pancreatic cancer	0.000546	0.00237	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000543	0.00235	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Erlotinib—pancreatic cancer	0.000541	0.00234	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000538	0.00511	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000537	0.00233	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.000536	0.00232	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Irinotecan—pancreatic cancer	0.000535	0.00232	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Sunitinib—pancreatic cancer	0.000528	0.00229	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000527	0.00228	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Doxorubicin—pancreatic cancer	0.000527	0.00228	CcSEcCtD
Adefovir Dipivoxil—Back pain—Irinotecan—pancreatic cancer	0.000526	0.00228	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Sunitinib—pancreatic cancer	0.000523	0.00227	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—NFE2L2—pancreatic cancer	0.000518	0.00492	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—pancreatic cancer	0.000517	0.00492	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000514	0.00223	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Sunitinib—pancreatic cancer	0.000513	0.00222	CcSEcCtD
Adefovir Dipivoxil—Back pain—Gemcitabine—pancreatic cancer	0.000512	0.00222	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000508	0.0022	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000504	0.00479	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000503	0.00478	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Irinotecan—pancreatic cancer	0.000502	0.00218	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Tamoxifen—pancreatic cancer	0.000497	0.00215	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—TGFA—pancreatic cancer	0.000494	0.0047	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Erlotinib—pancreatic cancer	0.000492	0.00213	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Erlotinib—pancreatic cancer	0.000492	0.00213	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00049	0.00213	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Gemcitabine—pancreatic cancer	0.000489	0.00212	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Docetaxel—pancreatic cancer	0.000488	0.00211	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000487	0.00463	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000485	0.00461	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SLC2A2—pancreatic cancer	0.000483	0.0046	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000481	0.00209	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Fluorouracil—pancreatic cancer	0.000481	0.00208	CcSEcCtD
Adefovir Dipivoxil—Cough—Irinotecan—pancreatic cancer	0.000474	0.00205	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Sunitinib—pancreatic cancer	0.000474	0.00205	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Docetaxel—pancreatic cancer	0.000472	0.00205	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Docetaxel—pancreatic cancer	0.000468	0.00203	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MYC—pancreatic cancer	0.000468	0.00445	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic failure—Epirubicin—pancreatic cancer	0.000468	0.00203	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Sunitinib—pancreatic cancer	0.000468	0.00203	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000465	0.00201	CcSEcCtD
Adefovir Dipivoxil—Cough—Gemcitabine—pancreatic cancer	0.000462	0.002	CcSEcCtD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—pancreatic cancer	0.000461	0.00439	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000456	0.00433	CbGpPWpGaD
Adefovir Dipivoxil—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000455	0.00197	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Tamoxifen—pancreatic cancer	0.000451	0.00195	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Gemcitabine—pancreatic cancer	0.000451	0.00195	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Gemcitabine—pancreatic cancer	0.000451	0.00195	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PRSS1—pancreatic cancer	0.000448	0.00426	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000447	0.00194	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Erlotinib—pancreatic cancer	0.000446	0.00193	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000445	0.00193	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Tamoxifen—pancreatic cancer	0.000445	0.00193	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Fluorouracil—pancreatic cancer	0.000443	0.00192	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Fluorouracil—pancreatic cancer	0.000443	0.00192	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Epirubicin—pancreatic cancer	0.000442	0.00192	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000441	0.0042	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Defective B3GAT3 causes JDSSDHD—CD44—pancreatic cancer	0.000441	0.00419	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00044	0.00191	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Erlotinib—pancreatic cancer	0.00044	0.00191	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Irinotecan—pancreatic cancer	0.000435	0.00188	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000434	0.00188	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000434	0.00412	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic failure—Doxorubicin—pancreatic cancer	0.000433	0.00188	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Docetaxel—pancreatic cancer	0.000431	0.00187	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Tamoxifen—pancreatic cancer	0.00043	0.00186	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MMP9—pancreatic cancer	0.000429	0.00408	CbGpPWpGaD
Adefovir Dipivoxil—Pharyngitis—Docetaxel—pancreatic cancer	0.000428	0.00186	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000426	0.00185	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Sunitinib—pancreatic cancer	0.000426	0.00184	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Sunitinib—pancreatic cancer	0.000426	0.00184	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Erlotinib—pancreatic cancer	0.000425	0.00184	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000424	0.00184	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000424	0.00184	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Docetaxel—pancreatic cancer	0.000423	0.00183	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000423	0.00183	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Irinotecan—pancreatic cancer	0.000423	0.00183	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Gemcitabine—pancreatic cancer	0.00042	0.00182	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000416	0.00181	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000416	0.0018	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—pancreatic cancer	0.000415	0.00395	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Gemcitabine—pancreatic cancer	0.000412	0.00178	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00041	0.0039	CbGpPWpGaD
Adefovir Dipivoxil—Renal impairment—Doxorubicin—pancreatic cancer	0.000409	0.00177	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Fluorouracil—pancreatic cancer	0.000405	0.00175	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000405	0.00385	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000403	0.00383	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Tamoxifen—pancreatic cancer	0.0004	0.00173	CcSEcCtD
Adefovir Dipivoxil—Rash—Tamoxifen—pancreatic cancer	0.000396	0.00172	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Tamoxifen—pancreatic cancer	0.000396	0.00172	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Erlotinib—pancreatic cancer	0.000395	0.00171	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000394	0.00171	CcSEcCtD
Adefovir Dipivoxil—Headache—Tamoxifen—pancreatic cancer	0.000394	0.00171	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000394	0.00171	CcSEcCtD
Adefovir Dipivoxil—Rash—Erlotinib—pancreatic cancer	0.000392	0.0017	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Erlotinib—pancreatic cancer	0.000392	0.0017	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Irinotecan—pancreatic cancer	0.00039	0.00169	CcSEcCtD
Adefovir Dipivoxil—Headache—Erlotinib—pancreatic cancer	0.00039	0.00169	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—ARG2—pancreatic cancer	0.000389	0.00369	CbGpPWpGaD
Adefovir Dipivoxil—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000388	0.00168	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000387	0.00168	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Sunitinib—pancreatic cancer	0.000386	0.00167	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Irinotecan—pancreatic cancer	0.000385	0.00167	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—pancreatic cancer	0.000384	0.00366	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000383	0.00166	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Sunitinib—pancreatic cancer	0.000381	0.00165	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Docetaxel—pancreatic cancer	0.000376	0.00163	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Gemcitabine—pancreatic cancer	0.000375	0.00163	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Fluorouracil—pancreatic cancer	0.000374	0.00162	CcSEcCtD
Adefovir Dipivoxil—Nausea—Tamoxifen—pancreatic cancer	0.000373	0.00162	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000373	0.00162	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—HSPA1A—pancreatic cancer	0.000372	0.00353	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000371	0.00161	CcSEcCtD
Adefovir Dipivoxil—Nausea—Erlotinib—pancreatic cancer	0.000369	0.0016	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Fluorouracil—pancreatic cancer	0.000369	0.0016	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Sunitinib—pancreatic cancer	0.000368	0.0016	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000367	0.00159	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000365	0.00158	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000363	0.00346	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Docetaxel—pancreatic cancer	0.000363	0.00157	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000363	0.00157	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000359	0.00156	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—NFE2L2—pancreatic cancer	0.000359	0.00341	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Epirubicin—pancreatic cancer	0.000356	0.00154	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MYC—pancreatic cancer	0.000355	0.00337	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Irinotecan—pancreatic cancer	0.000351	0.00152	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Irinotecan—pancreatic cancer	0.000351	0.00152	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000348	0.00331	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Docetaxel—pancreatic cancer	0.000347	0.0015	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000343	0.00149	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFA—pancreatic cancer	0.000342	0.00325	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Sunitinib—pancreatic cancer	0.000342	0.00148	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Gemcitabine—pancreatic cancer	0.000341	0.00148	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—TYMP—pancreatic cancer	0.00034	0.00323	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Sunitinib—pancreatic cancer	0.000339	0.00147	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Sunitinib—pancreatic cancer	0.000339	0.00147	CcSEcCtD
Adefovir Dipivoxil—Headache—Sunitinib—pancreatic cancer	0.000337	0.00146	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—SHH—pancreatic cancer	0.000337	0.0032	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Fluorouracil—pancreatic cancer	0.000336	0.00146	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SLC2A2—pancreatic cancer	0.000335	0.00319	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Doxorubicin—pancreatic cancer	0.00033	0.00143	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Epirubicin—pancreatic cancer	0.000329	0.00143	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000329	0.00312	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000329	0.00312	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Docetaxel—pancreatic cancer	0.000328	0.00142	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Docetaxel—pancreatic cancer	0.00032	0.00139	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Docetaxel—pancreatic cancer	0.00032	0.00139	CcSEcCtD
Adefovir Dipivoxil—Nausea—Sunitinib—pancreatic cancer	0.00032	0.00139	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Epirubicin—pancreatic cancer	0.000319	0.00138	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Irinotecan—pancreatic cancer	0.000318	0.00138	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000318	0.00138	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000316	0.00301	CbGpPWpGaD
Adefovir Dipivoxil—Jaundice—Epirubicin—pancreatic cancer	0.000316	0.00137	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000315	0.00299	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PRSS1—pancreatic cancer	0.000311	0.00295	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Gemcitabine—pancreatic cancer	0.00031	0.00134	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Epirubicin—pancreatic cancer	0.000309	0.00134	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000307	0.00133	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—SLC2A2—pancreatic cancer	0.000306	0.00291	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Gemcitabine—pancreatic cancer	0.000306	0.00132	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—pancreatic cancer	0.000304	0.00132	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—pancreatic cancer	0.000304	0.00132	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Irinotecan—pancreatic cancer	0.000303	0.00131	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000303	0.00288	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Docetaxel—pancreatic cancer	0.000301	0.0013	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Fluorouracil—pancreatic cancer	0.0003	0.0013	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Docetaxel—pancreatic cancer	0.0003	0.0013	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Docetaxel—pancreatic cancer	0.000298	0.00129	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000296	0.00282	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Gemcitabine—pancreatic cancer	0.000296	0.00128	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Doxorubicin—pancreatic cancer	0.000295	0.00128	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Doxorubicin—pancreatic cancer	0.000292	0.00127	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Docetaxel—pancreatic cancer	0.000292	0.00127	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—pancreatic cancer	0.000291	0.00277	CbGpPWpGaD
Adefovir Dipivoxil—Hepatitis—Epirubicin—pancreatic cancer	0.000291	0.00126	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Fluorouracil—pancreatic cancer	0.000291	0.00126	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—pancreatic cancer	0.000289	0.00125	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000287	0.00125	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Doxorubicin—pancreatic cancer	0.000286	0.00124	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000286	0.00124	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—pancreatic cancer	0.000285	0.00124	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000284	0.0027	CbGpPWpGaD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000284	0.00123	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Irinotecan—pancreatic cancer	0.000282	0.00122	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—pancreatic cancer	0.000281	0.00122	CcSEcCtD
Adefovir Dipivoxil—Rash—Irinotecan—pancreatic cancer	0.00028	0.00121	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Irinotecan—pancreatic cancer	0.000279	0.00121	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000279	0.00121	CcSEcCtD
Adefovir Dipivoxil—Headache—Irinotecan—pancreatic cancer	0.000278	0.0012	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Gemcitabine—pancreatic cancer	0.000275	0.00119	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GLP1R—pancreatic cancer	0.000274	0.0026	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Gemcitabine—pancreatic cancer	0.000272	0.00118	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Gemcitabine—pancreatic cancer	0.000272	0.00118	CcSEcCtD
Adefovir Dipivoxil—Headache—Gemcitabine—pancreatic cancer	0.000271	0.00117	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Fluorouracil—pancreatic cancer	0.00027	0.00117	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Docetaxel—pancreatic cancer	0.00027	0.00117	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—ARG2—pancreatic cancer	0.000269	0.00256	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—DPYD—pancreatic cancer	0.000269	0.00256	CbGpPWpGaD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—pancreatic cancer	0.000269	0.00117	CcSEcCtD
Adefovir Dipivoxil—Rash—Fluorouracil—pancreatic cancer	0.000268	0.00116	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Fluorouracil—pancreatic cancer	0.000268	0.00116	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—pancreatic cancer	0.000267	0.00116	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Docetaxel—pancreatic cancer	0.000266	0.00115	CcSEcCtD
Adefovir Dipivoxil—Headache—Fluorouracil—pancreatic cancer	0.000266	0.00115	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000266	0.00115	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000265	0.00115	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000265	0.00115	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—pancreatic cancer	0.000264	0.00114	CcSEcCtD
Adefovir Dipivoxil—Nausea—Irinotecan—pancreatic cancer	0.000263	0.00114	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—HSPA1A—pancreatic cancer	0.000258	0.00245	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Gemcitabine—pancreatic cancer	0.000257	0.00111	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—SLC2A2—pancreatic cancer	0.000256	0.00243	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Epirubicin—pancreatic cancer	0.000253	0.0011	CcSEcCtD
Adefovir Dipivoxil—Nausea—Fluorouracil—pancreatic cancer	0.000252	0.00109	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000251	0.00109	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Epirubicin—pancreatic cancer	0.00025	0.00108	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000247	0.00235	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Epirubicin—pancreatic cancer	0.000245	0.00106	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000244	0.00232	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Docetaxel—pancreatic cancer	0.000242	0.00105	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Docetaxel—pancreatic cancer	0.000242	0.00105	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000242	0.0023	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—CD44—pancreatic cancer	0.000237	0.00225	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—EGF—pancreatic cancer	0.000236	0.00225	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—TYMP—pancreatic cancer	0.000235	0.00224	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PRSS1—pancreatic cancer	0.000235	0.00224	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—pancreatic cancer	0.000234	0.00102	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Epirubicin—pancreatic cancer	0.000234	0.00101	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Doxorubicin—pancreatic cancer	0.000231	0.001	CcSEcCtD
Adefovir Dipivoxil—Back pain—Doxorubicin—pancreatic cancer	0.000227	0.000983	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	0.000225	0.00214	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000224	0.00213	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Epirubicin—pancreatic cancer	0.000221	0.000958	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00022	0.00209	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Docetaxel—pancreatic cancer	0.00022	0.000953	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000219	0.00208	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000218	0.00208	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Docetaxel—pancreatic cancer	0.000217	0.00094	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Doxorubicin—pancreatic cancer	0.000217	0.000939	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000216	0.00206	CbGpPWpGaD
Adefovir Dipivoxil—Chest pain—Epirubicin—pancreatic cancer	0.000216	0.000935	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—pancreatic cancer	0.000216	0.000935	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—SMAD4—pancreatic cancer	0.000214	0.00204	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000214	0.000928	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000211	0.002	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Docetaxel—pancreatic cancer	0.00021	0.000909	CcSEcCtD
Adefovir Dipivoxil—Cough—Doxorubicin—pancreatic cancer	0.000205	0.000887	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—ARG2—pancreatic cancer	0.000204	0.00194	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—pancreatic cancer	0.000203	0.000879	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000202	0.000877	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Epirubicin—pancreatic cancer	0.000201	0.00087	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Doxorubicin—pancreatic cancer	0.0002	0.000865	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—pancreatic cancer	0.0002	0.000865	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000198	0.000859	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—CD44—pancreatic cancer	0.000198	0.00188	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Epirubicin—pancreatic cancer	0.000197	0.000854	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000195	0.00186	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Docetaxel—pancreatic cancer	0.000195	0.000845	CcSEcCtD
Adefovir Dipivoxil—Rash—Docetaxel—pancreatic cancer	0.000193	0.000838	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Docetaxel—pancreatic cancer	0.000193	0.000837	CcSEcCtD
Adefovir Dipivoxil—Headache—Docetaxel—pancreatic cancer	0.000192	0.000832	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.00019	0.00181	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GLP1R—pancreatic cancer	0.00019	0.0018	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GCG—pancreatic cancer	0.00019	0.0018	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000188	0.000816	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000188	0.000813	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000187	0.000812	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—DPYD—pancreatic cancer	0.000187	0.00177	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—pancreatic cancer	0.000186	0.000805	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000184	0.00175	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Doxorubicin—pancreatic cancer	0.000182	0.00079	CcSEcCtD
Adefovir Dipivoxil—Nausea—Docetaxel—pancreatic cancer	0.000182	0.000789	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—pancreatic cancer	0.000182	0.000789	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—pancreatic cancer	0.00018	0.000779	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000178	0.000774	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—STK11—pancreatic cancer	0.000178	0.0017	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TYMP—pancreatic cancer	0.000178	0.0017	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—SLC2A2—pancreatic cancer	0.000177	0.00168	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000175	0.00166	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000175	0.00166	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000174	0.000755	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000171	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IFNA5—pancreatic cancer	0.00017	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000169	0.000733	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—pancreatic cancer	0.000168	0.00073	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—pancreatic cancer	0.000166	0.000721	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000165	0.000716	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—pancreatic cancer	0.000163	0.000708	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—pancreatic cancer	0.000163	0.000708	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000163	0.00155	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000162	0.00154	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PPP2R5B—pancreatic cancer	0.00016	0.00152	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000156	0.000678	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000155	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—TYMS—pancreatic cancer	0.000153	0.00146	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PRSS1—pancreatic cancer	0.000152	0.00144	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ZNRF3—pancreatic cancer	0.000152	0.00144	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—pancreatic cancer	0.000151	0.000655	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—pancreatic cancer	0.000151	0.000655	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000149	0.00141	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Epirubicin—pancreatic cancer	0.000148	0.000643	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Epirubicin—pancreatic cancer	0.000146	0.000634	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—GLP1R—pancreatic cancer	0.000144	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000144	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—VEGFA—pancreatic cancer	0.000143	0.00136	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—DPYD—pancreatic cancer	0.000141	0.00135	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—pancreatic cancer	0.000141	0.000613	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—DTX1—pancreatic cancer	0.000137	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Doxorubicin—pancreatic cancer	0.000137	0.000595	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—CD44—pancreatic cancer	0.000137	0.0013	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	0.000136	0.00129	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Doxorubicin—pancreatic cancer	0.000135	0.000587	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—SLC2A2—pancreatic cancer	0.000134	0.00128	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GCG—pancreatic cancer	0.000132	0.00125	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Epirubicin—pancreatic cancer	0.000131	0.00057	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—TGFB1—pancreatic cancer	0.000131	0.00125	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—pancreatic cancer	0.000131	0.000567	CcSEcCtD
Adefovir Dipivoxil—Rash—Epirubicin—pancreatic cancer	0.00013	0.000565	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—pancreatic cancer	0.00013	0.000564	CcSEcCtD
Adefovir Dipivoxil—Headache—Epirubicin—pancreatic cancer	0.00013	0.000561	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—PRSS1—pancreatic cancer	0.000127	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	0.000125	0.00119	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—APOE—pancreatic cancer	0.000125	0.00119	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000124	0.00118	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—STK11—pancreatic cancer	0.000124	0.00118	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Epirubicin—pancreatic cancer	0.000123	0.000532	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Doxorubicin—pancreatic cancer	0.000122	0.000527	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000121	0.00115	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Doxorubicin—pancreatic cancer	0.000121	0.000523	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—pancreatic cancer	0.00012	0.000522	CcSEcCtD
Adefovir Dipivoxil—Headache—Doxorubicin—pancreatic cancer	0.00012	0.000519	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—TGFB1—pancreatic cancer	0.000117	0.00111	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—DTX4—pancreatic cancer	0.000115	0.00109	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Doxorubicin—pancreatic cancer	0.000114	0.000492	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CG—pancreatic cancer	0.000113	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000112	0.00106	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PPP2R5B—pancreatic cancer	0.000112	0.00106	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ARG2—pancreatic cancer	0.00011	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PPARG—pancreatic cancer	0.000109	0.00103	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HEY2—pancreatic cancer	0.000108	0.00102	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000107	0.00102	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—TYMS—pancreatic cancer	0.000106	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	0.000106	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—CTNNB1—pancreatic cancer	0.000105	0.000998	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	0.000105	0.000996	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CD44—pancreatic cancer	0.000104	0.000989	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PRSS1—pancreatic cancer	0.000102	0.000969	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HEY1—pancreatic cancer	9.98e-05	0.000948	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GCG—pancreatic cancer	9.97e-05	0.000948	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CD—pancreatic cancer	9.9e-05	0.000942	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TYMP—pancreatic cancer	9.63e-05	0.000916	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CD44—pancreatic cancer	9.6e-05	0.000913	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—STK11—pancreatic cancer	9.37e-05	0.000891	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	9.34e-05	0.000888	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	9.32e-05	0.000886	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IFNA1—pancreatic cancer	9.3e-05	0.000884	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—JAG2—pancreatic cancer	8.85e-05	0.000841	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ARG2—pancreatic cancer	8.84e-05	0.000841	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MEN1—pancreatic cancer	8.72e-05	0.000829	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC2A2—pancreatic cancer	8.66e-05	0.000823	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IFNA2—pancreatic cancer	8.65e-05	0.000823	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—APOE—pancreatic cancer	8.65e-05	0.000823	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CB—pancreatic cancer	8.63e-05	0.000821	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTGS2—pancreatic cancer	8.55e-05	0.000813	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—MYC—pancreatic cancer	8.5e-05	0.000808	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SHH—pancreatic cancer	8.32e-05	0.000791	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IAPP—pancreatic cancer	8.21e-05	0.000781	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	8.12e-05	0.000772	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFB1—pancreatic cancer	8.11e-05	0.000771	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TYMS—pancreatic cancer	8.06e-05	0.000767	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HSPA1B—pancreatic cancer	7.89e-05	0.00075	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CG—pancreatic cancer	7.81e-05	0.000742	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GLP1R—pancreatic cancer	7.77e-05	0.000738	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TYMP—pancreatic cancer	7.73e-05	0.000735	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—DPYD—pancreatic cancer	7.64e-05	0.000726	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PPARG—pancreatic cancer	7.54e-05	0.000716	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTEN—pancreatic cancer	7.46e-05	0.000709	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC2A2—pancreatic cancer	7.25e-05	0.000689	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—JAG1—pancreatic cancer	7.06e-05	0.000671	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CD—pancreatic cancer	6.86e-05	0.000653	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD44—pancreatic cancer	6.7e-05	0.000637	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HSPA1A—pancreatic cancer	6.66e-05	0.000633	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—APOE—pancreatic cancer	6.56e-05	0.000623	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	6.51e-05	0.000619	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	6.34e-05	0.000603	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GLP1R—pancreatic cancer	6.23e-05	0.000592	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLAU—pancreatic cancer	6.14e-05	0.000584	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—DPYD—pancreatic cancer	6.13e-05	0.000583	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CB—pancreatic cancer	5.98e-05	0.000569	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—pancreatic cancer	5.93e-05	0.000564	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CG—pancreatic cancer	5.92e-05	0.000563	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	5.82e-05	0.000553	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC2A2—pancreatic cancer	5.82e-05	0.000553	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPARG—pancreatic cancer	5.71e-05	0.000543	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CD44—pancreatic cancer	5.61e-05	0.000534	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CG—pancreatic cancer	5.46e-05	0.000519	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—EGF—pancreatic cancer	5.4e-05	0.000513	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GCG—pancreatic cancer	5.38e-05	0.000512	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SMAD4—pancreatic cancer	5.29e-05	0.000503	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—pancreatic cancer	5.26e-05	0.0005	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CD—pancreatic cancer	5.2e-05	0.000495	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTEN—pancreatic cancer	5.17e-05	0.000492	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HES1—pancreatic cancer	5.17e-05	0.000491	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—STK11—pancreatic cancer	5.06e-05	0.000481	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	4.95e-05	0.000471	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CD—pancreatic cancer	4.8e-05	0.000457	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CB—pancreatic cancer	4.53e-05	0.000431	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TERT—pancreatic cancer	4.53e-05	0.000431	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CD44—pancreatic cancer	4.5e-05	0.000428	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—pancreatic cancer	4.49e-05	0.000427	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TYMS—pancreatic cancer	4.35e-05	0.000414	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HIF1A—pancreatic cancer	4.33e-05	0.000412	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TSC2—pancreatic cancer	4.32e-05	0.000411	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GCG—pancreatic cancer	4.32e-05	0.00041	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—pancreatic cancer	4.3e-05	0.000409	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APOE—pancreatic cancer	4.23e-05	0.000402	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CB—pancreatic cancer	4.19e-05	0.000398	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—STK11—pancreatic cancer	4.06e-05	0.000386	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	4.04e-05	0.000384	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTEN—pancreatic cancer	3.92e-05	0.000373	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOTCH1—pancreatic cancer	3.9e-05	0.000371	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGF—pancreatic cancer	3.77e-05	0.000359	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—pancreatic cancer	3.65e-05	0.000347	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—APOE—pancreatic cancer	3.54e-05	0.000337	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TYMS—pancreatic cancer	3.49e-05	0.000332	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SRC—pancreatic cancer	3.35e-05	0.000319	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CD—pancreatic cancer	3.35e-05	0.000319	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—pancreatic cancer	3.27e-05	0.000311	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NRAS—pancreatic cancer	3.23e-05	0.000307	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CG—pancreatic cancer	3.2e-05	0.000304	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPARG—pancreatic cancer	3.08e-05	0.000293	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB1—pancreatic cancer	3e-05	0.000285	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—pancreatic cancer	2.98e-05	0.000283	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CB—pancreatic cancer	2.92e-05	0.000278	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—pancreatic cancer	2.9e-05	0.000275	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—APOE—pancreatic cancer	2.84e-05	0.00027	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CD—pancreatic cancer	2.81e-05	0.000267	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KRAS—pancreatic cancer	2.78e-05	0.000264	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—pancreatic cancer	2.76e-05	0.000263	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CTNNB1—pancreatic cancer	2.59e-05	0.000246	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CG—pancreatic cancer	2.56e-05	0.000244	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	2.55e-05	0.000243	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTEN—pancreatic cancer	2.53e-05	0.00024	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPARG—pancreatic cancer	2.47e-05	0.000235	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—pancreatic cancer	2.47e-05	0.000235	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CB—pancreatic cancer	2.45e-05	0.000233	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—pancreatic cancer	2.43e-05	0.000231	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—pancreatic cancer	2.36e-05	0.000224	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SRC—pancreatic cancer	2.34e-05	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT3—pancreatic cancer	2.26e-05	0.000215	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—pancreatic cancer	2.26e-05	0.000215	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NRAS—pancreatic cancer	2.25e-05	0.000214	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CD—pancreatic cancer	2.25e-05	0.000214	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTEN—pancreatic cancer	2.12e-05	0.000201	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—pancreatic cancer	2.1e-05	0.0002	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFB1—pancreatic cancer	2.09e-05	0.000199	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—pancreatic cancer	2.08e-05	0.000198	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—pancreatic cancer	2.05e-05	0.000195	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CB—pancreatic cancer	1.96e-05	0.000187	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—pancreatic cancer	1.95e-05	0.000185	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KRAS—pancreatic cancer	1.94e-05	0.000184	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—pancreatic cancer	1.78e-05	0.000169	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTEN—pancreatic cancer	1.7e-05	0.000161	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—pancreatic cancer	1.65e-05	0.000157	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—pancreatic cancer	1.49e-05	0.000142	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—pancreatic cancer	1.46e-05	0.000138	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—pancreatic cancer	1.22e-05	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—pancreatic cancer	1.2e-05	0.000114	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—pancreatic cancer	9.78e-06	9.3e-05	CbGpPWpGaD
